Personal Care Molecular Imaging

Personal Care Molecular Imaging Dr. Krynyckyi started PCMI, initially with the GE PET/CT DSTE scanner, at the time superior to all locally. The goal of PCMI was to provide cutting edge technology as well as the absolute best in PET/CT interpretation....

Personal Care Molecular Imaging Dr. Krynyckyi started PCMI, initially with the GE PET/CT DSTE scanner, at the time superior to all locally. The goal of PCMI was to provide cutting edge technology as well as the absolute best in PET/CT interpretation. Superior results were obtained by utilizing the best camera, meticulous attention to detail, optimizations from injection to interpretation, including the ATLAS3 system of lesion tracking, unrivaled in the industry. Today, Dr. Krynyckyi is proud to continue to be again at the forefront of technology by introducing GE’s NEWEST Digital PET/CT scanner, the GE Discovery MI. This scanner is the only true digital PET/CT scanner in the state, with less radiation, and markedly improved image detail/resolution. Dr Krynyckyi spends the time to carefully and completely interpret the scans with personal attention to details. His dedication, compassion, and caring, along with that of his staff, and comfortable spa-like facility, offer the highest quality of medicine available. PERSONAL CARE MOLECULAR IMAGING (732)-681-2700 The home of State of the Art imaging, lesion tracking (ATLAS-3), and interpretation, now offers FDG PET/CT and NAF PET/CT Bone Scans, along with Axumin scans for recurrent Prostate cancer, as well as NetSpot Ga 68 for Neuroendocrine tumor imaging. Our facility also offers Amyloid Brain imaging for memory loss/Alzheimer’s with the latest FDA approved radiotracers. FDG PET/CT utilizing the combination of FDG Positron Emission Tomography (PET) and Computerized Tomography (CT), detects the location of cancer in the body before and after treatment. FDG PET/CT has become a powerful tool in oncology and is helping to cure patients and extend their lives. NAF PET/CT Sodium Fluoride Bone Scan images the entire skeletal system. Detects areas of destruction of bone associated with tumors which may have spread from other areas of the body such as breast or prostate cancer; replaces suboptimal inaccurate conventional bone scans. Axumin PET/CT detects suspected recurrence of Prostate cancer in men who have been treated with prostatectomy and/or radiotherapy, but continue to have elevated Prostate Specific Antigen (PSA), i.e biochemical recurrence. NetSpot (Ga 68) PET/CT imaging for the detection and management of somatostatin receptor positive Neuroendicrine tumors; is far superior to and replaces the outdated Indium-111 Octreotide scans which in the past were done over two days and many hours of imaging. NetSpot Ga68 is SUPERIOR